MoneyWorks4Me

Lupin reports 40% rise in Q2 net profit

30 Oct 2013 Evaluate

Lupin has reported results for the second quarter ended September 30, 2013.

The company has reported 151.33% rise in its net profit at Rs 809.12 crore for the quarter as compared to Rs 321.94 crore for the same quarter in the previous year. Total income of the company has increased by 44.67% at Rs 2541.48 crore for quarter under review as compared to Rs  1756.70 crore for the quarter ended September 30, 2012.

On the consolidated basis, the group has registered a growth of 39.84% in net profit after taxes & Minority Interest at Rs 406.18 crore as compared to Rs 290.46 crore in the same quarter previous year. Total income of the group rose 19.27% to Rs 2749.23 crore for quarter under review as against Rs 2305.00 crore in corresponding quarter previous year.

Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1250.00
Cipla 1383.00
Lupin 2060.00
Zydus Lifesciences 1195.20
View more..